Joff Masukawa

Board Member

Joff Masukawa is President and founder of Diligentia Strategy, a life-sciences consultancy founded in 2015 that develops commercialization strategies, government relations strategy and services for manufacturers of rare orphan and specialty drugs, cell and gene therapies, and other novel emerging medical innovations.

Prior to founding Diligentia, Joff was Vice President and Global Head of Government Relations and Public Affairs at Shire. Joff has held senior level leadership roles spanning commercial and corporate functions, including market access, government and public affairs, patient and provider services, and sales and marketing at Shire, Genzyme, Visible Genetics, Gentiva and Labcorp.

He serves on the boards of Phoenicis Therapeutics, Caregiver Action Network, and the Center for Healthcare Innovation. Joff is also an advisor to America’s Health Foundation and a member of the American Society of Gene and Cell Therapy and the Innovation and Value Initiative.

He holds a BA in international studies from Johns Hopkins University and completed his graduate studies in international affairs at the Johns Hopkins School of International Studies and in strategic communications at Columbia University.